Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women

Advertisement

---

The Economics and Challenges of Breast Cancer in a Managed Care Environment

Based on a presentation by Alan H. Heaton, PharmD

June 1st 1999

ArticleSPECIAL FEATURE

---

Participating Faculty

June 1st 1999

ArticleSUPPLEMENT CONTENT

---

Medical and Economic Impact of Breast Cancer Treatment and Prevention

C. Alan Lyles, ScD, MPH, RPh

June 1st 1999

ArticleINTRODUCTION

---

Benefits Foregone: Too Much of the Wrong and Too Little of the Right

Bernard S. Bloom, PhD

June 1st 1999

ArticleSUPPLEMENT CONTENT

---

Breast Cancer: Overview of Current Management Considerations of Economic Impact

Sandra E. Brooks, MD

June 1st 1999

ArticleSUPPLEMENT CONTENT

---

Breast Cancer Epidemiology: An Overview

Claudia R. Baquet, MD, MPH

June 1st 1999

ArticleSUPPLEMENT CONTENT

---

Overview of Cancer Economics

C. Daniel Mullins, PhD

June 1st 1999

ArticleSUPPLEMENT CONTENT

---

Breast Cancer Stage Cost Analysis in a Managed Care Population

Kenneth L. McDonough, MD

June 1st 1999

ArticleSUPPLEMENT CONTENT

---

The Cost Effectiveness of Tamoxifen in the Prevention of Breast Cancer

Les L. Noe, MPA, RPh;Russell V. Becker, III, MA;William J. Gradishar, MD;Mugdha Gore, PhD;Jeffrey P. Trotter, MM

June 1st 1999

ArticleSUPPLEMENT CONTENT

---

Question-and-Answer Session

June 1st 1999

ArticleSUPPLEMENT CONTENT

Advertisement

---

Selected Abstracts

June 1st 1999

ArticleSUPPLEMENT CONTENT

---

CME Quiz

June 1st 1999

ArticleSUPPLEMENT CONTENT

---

Bibliography

June 1st 1999

ArticleSUPPLEMENT CONTENT